Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA.
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 237, doi. 10.3390/immuno3020016
- By:
- Publication type:
- Article
Works matching IS 26735601 AND DT 2023 AND VI 3 AND IP 2
Results: 8
1
2
Inflammatory Profile of Th9 Cells and Their Protective Potential in Helminth Infections.
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 228, doi. 10.3390/immuno3020015
- By:
- Publication type:
- Article
3
Exploring the Potential of Plant-Based CTB-INS Oral Vaccines in Treating Type 1 Diabetes.
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 217, doi. 10.3390/immuno3020014
- By:
- Publication type:
- Article
4
Immunopathogenesis of Nipah Virus Infection and Associated Immune Responses.
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 160, doi. 10.3390/immuno3020011
- By:
- Publication type:
- Article
5
Current Advancements and Future Perspectives of Immunotherapy in Breast Cancer Treatment.
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 195, doi. 10.3390/immuno3020013
- By:
- Publication type:
- Article
6
Medicinal Plant Enriched Metal Nanoparticles and Nanoemulsion for Inflammation Treatment: A Narrative Review on Current Status and Future Perspective.
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 182, doi. 10.3390/immuno3020012
- By:
- Publication type:
- Article
7
Anti-Inflammatory and Anti-Adipogenesis Effects of Alchemilla vulgaris L., Salvia officinalis L., and Vitis vinifera L. in THP-1-Derived Macrophages and 3T3-L1 Cell Line.
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 148, doi. 10.3390/immuno3020010
- By:
- Publication type:
- Article
8
Mimicry of Tumour-Associated Carbohydrates: Is It a Promising Option for Cancer Treatment?
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 122, doi. 10.3390/immuno3020009
- By:
- Publication type:
- Article